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ABSTRACT
In recent decades, tissue engineering strategies have been proposed for the treatment of musculoskel-
etal diseases and bone fractures to overcome the limitations of the traditional surgical approaches
based on allografts and autografts. In this work we report the development of a composite porous
poly(DL-lactide-co-glycolide) scaffold suitable for bone regeneration. Scaffolds were produced by thermal
sintering of porous microparticles. Next, in order to improve cell adhesion to the scaffold and subse-
quent proliferation, the scaffolds were coated with the osteoconductive biopolymers chitosan and
sodium alginate, in a process that exploited electrostatic interactions between the positively charged
biopolymers and the negatively charged PLGA scaffold. The resulting scaffolds were characterized in
terms of porosity, degradation rate, mechanical properties, biocompatibility and suitability for bone
regeneration. They were found to have an overall porosity of 85% and a degradation half time of
2weeks, considered suitable to support de novo bone matrix deposition from mesenchymal stem
cells. Histology confirmed the ability of the scaffold to sustain adipose-derived mesenchymal stem cell
adhesion, infiltration, proliferation and osteo-differentiation. Histological staining of calcium and micro-
analysis confirmed the presence of calcium phosphate in the scaffold sections.
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Tissue engineering is the third therapeutic strategy in the
broad area of regenerative medicine, after the first two strat-
egies, i.e. organ transplantation and reconstructive surgery,
which have been contributing to save and improve countless
lives over the years, but which nonetheless remain partial
and imperfect solutions [1,2]. Tissue engineering approaches
have been studied for almost all the tissues of the human
body with relatively promising results [3].
Unlike other tissues, bone can regenerate itself and in
most cases, bone injuries heal without scar formation, as is
the case, for example, with fractured bones. Even so, bone
is one of the most frequently transplanted tissues [4]. The
increase of the elderly population will inevitably lead to an
increasingly frail population at greater risk of bone fracture,
caused not only by accidental falls, but also by diseases
such as osteoarthritis and osteoporosis; this trend will place
a tremendous socio-economic burden on world healthcare
systems [5,6]. This may explain why the last two decades
have seen growing interest in and great expectations about
the possible applications of tissue engineering on bone
defects.
Bone defects include bone loss after infection or cancer,
bone fragility due to genetic diseases such as osteogenesis
imperfecta, as well as pathological fractures such as large
bone defects with delayed unions and non-unions. The trad-
itional approaches for treating bone defects include bone
allograft and autograft [7–9]. Autograft is still considered the
“gold standard” for healing bone defects. It possesses all the
requirements desired in a bone grafting material: it is osteo-
conductive (it provides a support for cell and bone tissue
ingrowth), osteoinductive (it provides the differentiation of
stem cells in osteogenic cells) and osteogenic (it holds viable
cells for the formation of new bone tissue) [10]. However, the
available volume of autologous bone graft from a patient is
limited and an additional surgical procedure is required to
harvest the grafting material, with a significant risk of donor
site morbidity and more pain for the patient. Allograft (substi-
tute bone obtained from a donor) is an alternative option
with major limitations associated with immunological rejec-
tion, transmission of diseases and cost. Moreover, due to the
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treatment to remove antigenicity, allografts do not contain
viable cells, and thus lack osteogenicity.
Due to the limitations of the traditional grafting
approaches, scientists are exploring the application of tissue
engineering strategies to facilitate bone healing and regener-
ation [7–11]. The main focus of bone tissue engineering is
the creation of an appropriate scaffold, which acts as a three-
dimensional support to guide de novo tissue formation.
Scaffolds must be biocompatible, and their surface features
must be such that they assure cell adhesion and attachment
[12]. They must have high porosity to allow cell migration
and proliferation and facilitate the transport of nutrients [13],
and their mechanical properties must match those of the tis-
sue. Similarly, their degradation rate must be in line with the
tissue regeneration kinetics [7,14].
In the current study, three-dimensional biodegradable
scaffolds were designed by sintering together poly(DL-lactide-
co-glycolide) (PLGA) porous microparticles (MPs) with tailored
porosity and size. To improve the scaffold-cell interaction, its
surface was coated with chitosan (CH) and alginate (AL), bio-
polymers that have demonstrated osteoconductive properties
[15,16]. The scaffolds were characterized in terms of morph-
ology, porosity, degradation rate, mechanical behaviour and
in vivo biocompatibility. Then, we investigated the ability of
this construct to support adipose-derived mesenchymal stem
cells (AD-MSCs) adhesion and differentiation as well as the
possibility of obtaining de novo bone matrix by calcium phos-
phate deposition. This study reports the feasibility of a bio-
compatible and biodegradable scaffold that can support
mesenchymal stem cell differentiation to bone and promote
significant calcium phosphate deposition.
Materials and methods
Materials
PLGA ResomerVR 502H (Mw 8000Da), with a 50:50 ratio of
lactic:glycolic acids, was supplied by Boehringer Ingelheim
(Ingelheim, Germany) and used as provided. Polyvinyl alcohol
(PVA) (Mw: 30,000–70,000Da), chondroitin-4-sulphate sodium
salt (CS) from bovine trachea, sorbitan monostearate (SpanVR
60), polysorbate 80 (TweenVR 80) and sodium azide were pur-
chased from Sigma-Aldrich (Milan, Italy). High mannuronic
sodium alginate (guluronic acid, 39%; mannuronic acid 61%)
and low molecular weight CH (Mw 150,000Da) were sup-
plied by Stern (Milan, Italy) and Fluka (Milan, Italy),
respectively.
Fertilized eggs used for chicken embryo chorioallantoic
membrane (CAM) assay were supplied by Azienda Agricola
Cerquaglia (Marsciano, Italy). Mayer’s haematoxylin, eosin and
alizarin red employed for histology staining were purchased
from Carlo Erba (Milan, Italy). Type I collagenase, Dulbecco's
Modified Eagle's medium (DMEM) and foetal bovine serum
(FBS) were supplied by Sigma-Aldrich (Milan, Italy), while the
commercial osteogenic induction medium PoieticsTM was pur-
chased from Lonza (Walkersville, MD, USA). All antibodies
(Abs) employed for flow cytometry were purchased from
Becton Dickinson (Frankin Lakes, NJ, USA), except for the PE-
conjugated anti-human CD73, supplied by Miltenyi Biotech
(Bologna, Italy). All FACS reagents were used in the concen-
trations recommended by the manufacturer.
Ultra-pure water was obtained from a New Human Power
system (Human Corporation, Seoul, Korea). All other chemi-
cals were of the highest purity commercially available and
used as provided.
Microparticle preparation and characterization
Porous PLGA MPs were prepared according to a water-in-
oil-in-water (W/O/W) double emulsion method [17]. After
an initial method optimization (Table S1), optimal MPs
were obtained using the following parameters: 1.5ml of 0.
1% (w/v) SpanVR 60 were emulsified in 3.5ml of CH2Cl2
containing 500mg of PLGA (W1/O). This primary emulsion
was slowly injected into 500ml of 0.1% w/v PVA solution
(W2) forming a W1/O/W2 emulsion that was stirred at
600 rpm until complete organic solvent evaporation. The
injection was performed at 4 C, then the temperature was
increased to 25 C, maintained at 25 C for 2 h, raised up
to 30 C for 1 h, and 40 C for 30min. The accuracy of the
temperature controller was ±1 C. After the MP formation
and hardening, the temperature was lowered to 15 C and
the dispersion was filtered using a cellulose filter having a
pore size of 2.5 mm (WhatmanVR , Maidstone, UK), washed
three times with ultrapure water. MPs were dried at room
temperature overnight and for an additional 12 h under
vacuum.
Microparticle mean diameter and size distribution were
estimated with an Accusizer C770 (PSS Inc. Santa Barbara,
USA) equipped with an autodiluting system (AutodiluterPAT,
PSS Inc. Santa Barbara, CA, USA). Dried MPs were suspended
in 1ml of ultrapure water containing 0.5% (w/v) of polysor-
bate 80 to prevent MP aggregation. Analyses were performed
in triplicate and size was expressed as mean volume diameter
(dmv) ± standard deviation.
Microparticle morphology was investigated by scanning
electron microscopy (SEM) using a Philips XL30 microscope
(Philips Electron Optics, Eindhoven, Netherlands). Samples
were prepared by placing a small amount of MPs onto an
aluminium specimen stub. The samples were sputter coated
with gold prior to imaging (EMITECH K-550X sputter coater
Ashford, Kent, UK). Coating was performed at 35mA for
3min.
Scaffold preparation and characterization
Scaffolds were prepared using the thermal sintering tech-
nique [18]. PLGA MPs were placed in a cylindrical mould
(diameter: 7mm; depth: 5mm) and incubated at different
temperatures and times to identify the optimal conditions
for obtaining scaffolds with the desired characteristics. The
optimized scaffold was prepared sintering 200mg of MPs
at 60 ± 2 C for 1 h. The scaffold was then coated with CH
and AL [19,20]. Briefly, the scaffold was dipped in 5ml of a
1% (w/v) CH solution for 15min, then in 5ml of a 1%
(w/v) AL solution for 15min, washed in 5ml of distilled
water for 15min and finally lyophilized using a Virtis
Benchtop Freeze Dryer 8 l 105 C (Ipswich, UK) at 80 C
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and 158 mtor of temperature and pressure, respectively.
Hereafter, the CH and AL coated scaffold is referred to as
‘coated scaffold’, while the bare scaffold is referred to as
“uncoated scaffold”.
To assess the efficacy of the coating procedure, scaffolds
were also coated with CS instead of AL and the presence of
the external polyanion was detected by microanalysis using a
Philips XL30 SEM (Philips Electron Optics, Eindhoven,
Netherlands) coupled with an EDAX Philips system equipped
with an LaB6 source and an EDAX/DX4 detector. Scaffolds
were sputter coated with gold prior to imaging (EMITECH K-
550X sputter coater Ashford, Kent, UK). Coating was per-
formed at 35mA for 3min.
Scaffold surfaces were also analysed by Attenuated Total
Reflection-Fourier Transform Infrared Spectroscopy (ATR-FTIR)
(Fourier Nicolet AVATAR 360N equipped with a Nicolet Smart
DuraScope sensor, a video-enhanced diamond ATR and an
integrated camera). The operating parameters were the fol-
lowing: sampled area, 1.5mm2; sampled volume, 2 mL; pene-
tration, 2mm; number of scan, 64.
Scaffold porosity was estimated using computed tomog-
raphy (CT) scans performed by a VimagoTM CT Scanner (Epica
Medical Innovations, San Clemente, CA, USA) with a reso-
lution of 100 mm and true isotropic voxels. Scans were done
with an energy level of 65 kV, an exposure time of 5ms and
an X-ray tube current of 25mA. Image slices were acquired
with a thickness and a pixel size of 90 mm.
Computed tomography image segmentation was per-
formed using open access MicroDicom software; a region of
interest (ROI) of 8 8mm was chosen for each slice and a
threshold was used to create a black/white image of the slice.
The percentage of white pixels relative to the total number
of pixels of the ROI was estimated using a custom-made
script within MATLAB (The MathWorks, Inc., Natick, MA, USA)
for each slice. Then, porosity was calculated as the mean of
the percentage of white pixels relative to the total number of
pixels for each slice. The results were expressed as the mean
of three independent measurements for both uncoated and
coated scaffolds.
Scaffold degradation
Scaffold degradation was evaluated by in vitro mass loss stud-
ies and gel permeation chromatography (GPC).
Scaffolds were inserted in a closed tea bag built with a
polyester net (pore diameter 30 mm) and incubated in 40ml
of phosphate-buffered saline (PBS) (0.1M, pH 7.4) containing
0.02% (w/v) of sodium azide at 37 C. Scaffolds were with-
drawn after 1 h (T0) and 1 (T1), 7 (T7), 14 (T14), 21 (T21) and
28 (T28) days, washed with 50ml of ultrapure water, wiped
with filter paper and vacuum dried overnight. The analysis
was performed in triplicate and the error was expressed as
standard deviation.
Mass loss (ML) and residual mass (RM) were calculated as
follows




RMð%Þ ¼ Mass recovered after incubation
Initial mass
 100 (2)
Polymer molecular weight (Mw) and molecular number
(Mn) of the scaffolds were determined by a HP1100
Chemstation (Hewlett-Packard, Palo Alto, CA, USA) equipped
with a combination of two columns: mStyragelTM Toluene
104Å 7.8 300mm and mStyragelTM Toluene 103Å
7.8 300mm (Waters, Vimodrone, Italy). The chromatographic
conditions used were the following: tetrahydrofuran as a
mobile phase; flow rate of 1.0ml min1; refractive index sig-
nal as detector; injection volume of 20 mL. The Mw of each
sample was calculated using a calibration curve built using
monodisperse polystyrene standards with Mw ranging from
1000 to 45,000Da.
The apparent degradation rate (K) based on Mw and Mn
was obtained by:
logM ¼ logM0  K (3)
where M is the polymer Mw or Mn at time t, M0 is the poly-
mer Mw or Mn at time zero.
The polymer degradation half time (t1/2) was further calcu-
lated by:
t1=2 ¼ log 2=K (4)
Morphological changes during the in vitro degradation
experiments were followed by SEM (Zeiss LEO 1525 equipped
with a GEMINI column, Oberkochen, Germany). Dried scaf-
folds were placed on an aluminum stub by double-sided
adhesive carbon tape and sputter-coated with graphite for
20 s.
Mechanical tests
Compression tests of uncoated and coated scaffolds were
performed with a universal loading frame machine
InstronTM 5965 (Instron Inc., Norwood, MA, USA) equipped
with a 5 kN load cell on the movable part to record the
compressive force during the test. The upper plate moved
down at a fixed speed of 0.1mm/s, compressing the scaf-
fold against the lower plate until reaching half of the initial
thickness. Dried scaffolds and scaffolds incubated in PBS
(0.1M, pH¼ 7.4, with 0.02% w/v of sodium azide) at
37 ± 1 C and withdrawn at 1 h (T0) and 1 (T1), 7 (T7), 14
(T14), 21 (T21) and 28 (T28) days were tested. Scaffold
dimensions were assumed equal to compare data of com-
pression tests (5mm of thickness and 15mm of width). The
Young’s modulus was calculated as the ratio between com-
pressive stress and strain in the linear portion of the curve.
Tests were executed using four scaffolds for each group
and results were expressed as mean± standard deviation.
Statistical analysis was performed using MATLAB software
(The MathWorks, Inc., Natick, MA, USA). Comparison
between uncoated and coated scaffolds was done by stu-
dent t-test and the difference was considered to be statis-
tically significant if p< .05.
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In vivo biocompatibility studies
Chorioallantoic membrane assay was performed to evaluate
the in vivo biocompatibility of coated and uncoated scaffolds
[21]. Fertilized eggs were incubated at 38 ± 1 C and 60% of
relative humidity in a ventilated non rocking oven. On day 3,
an opening with a diameter of about 3 cm was made on the
obtuse pole of the eggshell and viable embryos were
selected for the experiment. The eggshell window was closed
with a polyethylene film to avoid water loss and microbial
contamination. Four days later (day 7 of development),
uncoated and coated scaffolds were deposited on the CAM
surface. Embryos were monitored for macroscopic signs of
toxicity and photographed every day until day 12 of develop-
ment [22,23]. Embryos were sacrificed at day 12 and the por-
tions of CAM with the scaffolds were sampled and fixed in
4% (w/v) paraformaldehyde in PBS (pH 7.4). Samples were
dehydrated in ethanol solutions of growing order of grad-
ation (from 70 to 100), treated in xylol and then embedded
in paraffin. Each sample was cut with a rotary microtome (RM
2145 Leica Microsystems, Nussloch, Germany) into 10 lm
slides (orthogonal section) that were treated with xylol to
eliminate the paraffin and then with ethanol (decreasing
order of gradation) to allow the staining. CAM was stained
with Mayer’s haematoxylin solution and eosin. After staining,
the slides were again dehydrated and mounted with coverslip
in Canada balsam before histological examination, performed
with a Leica DMLB light microscope (Wetzlar, Germany),
equipped with a Leica DFC 320 high-resolution camera.
Isolation and characterization of adipose-derived
mesenchymal stem cell
Tissue isolation
Infra-patellar fat-pat-biopsies were isolated from patients
undergoing total knee arthroplasty at the International
Orthopedic and Traumatologic Institute (IOTI) (Arezzo, Italy),
following a standardized protocol meeting the criteria estab-
lished by the American College of Rheumatology [24]. At the
beginning of the surgical procedures, infra-patellar fat pad
biopsies were collected and sent to IRTAL-LPMRI (Istituto di
Ricerca Traslazionale per l’Apparato Locomotore Nicola Cerulli
– Lpmri – S.r.l.) within 4 h.
Isolation of adipose-derived mesenchymal stem cells
Fat tissue biopsies were processed to obtain AD-MSCs. Briefly,
fat biopsies were washed extensively with sterile PBS supple-
mented with 5X antibiotics (500U/ml Pen/Strep) and treated
with 0.075% collagenase type I in PBS for 30min at 37 ± 1 C
under gentle agitation. Collagenase was inactivated with an
equal volume of DMEM/10% FBS and the infranatant was fil-
tered through a 70-lm mesh filter to remove tissue debris,
and then centrifuged (10min at 200g). The cellular pellet was
resuspended in DMEM/10% FBS, plated onto conventional tis-
sue culture plates in normal growth medium (NGM: DMEM
low glucose þ10% FBS þ100U/ml Pen/Strep), and expanded
until the third passage, after which they were used for the
experimental procedures.
Flow cytometry
Adipose-derived mesenchymal stem cells were cultured in
control medium for 72 h before analysis. Cells were harvested
in 0.25% trypsin/EDTA and washed three times in an isotonic
phosphate buffer (supplemented with 0.5% BSA). Washed
cells were re-suspended in PBS containing 0.5% FBS at a final
concentration of 1 106 cells/mL. All procedures were per-
formed at 4 C. The following Abs were used: FITC-labelled
rabbit anti-human CD90, CD105, CD271 and HLA-DR; PE-con-
jugated anti-human CD73, FITC–conjugated anti-CD14 mAb
(Leu M3) and PE-conjugated anti-CD16 mAb (Leu11). Flow
cytometry data acquisition was performed on a FACS Calibur
equipped with 488 and 633 nm lasers and running Cellquest
Software (Becton Dickinson, CA, USA). Ten thousand live-
gated events were collected for each sample and isotype
matched Abs were used to determine binding specificity. The
results were expressed both as a percentage of positive cells/
antibody used for staining (% positive cells) and as mean
fluorescence intensity (MFI).
AD-MSCs growth and osteogenic differentiation
AD-MSCs (total number 2.5 105) were seeded on coated
scaffolds in presence of the normal growth medium (NGM)
and cultured for 24 h. Afterwards, the AD-MSC osteogenic
differentiation was induced, replacing the NGM with a com-
mercial osteogenic differentiation medium containing dexa-
methasone, L-glutamine, ascorbate, mesenchymal cell
growth supplement, b-glycerophosphate, penicillin/strepto-
mycin, complemented following manufacturer instructions.
As experimental control, AD-MSCs were seeded in coated
scaffolds and cultured only in the NGM. The culture medium
was changed every three days and cells were maintained
in culture for 60 days. After selected time points (3, 7, 21,
35 and 60 days of culture), scaffolds were harvested and
washed with sterile PBS. Cells were fixed using PBS contain-
ing 4% (w/v) of paraformeldehyde and 1% (w/v) of
glutaraldehyde.
Fixed scaffolds were washed with ultrapure water,
embedded in optimum cutting temperature (OCT) compound
and frozen at -20 ± 1 C. Sixteen mm scaffold sections were
prepared using a Cryostat microtome. Cell proliferation and
penetration into scaffolds were evaluated by
Haematoxylin–Eosin (HE) staining. Briefly, scaffold sections
were incubated in Mayer’s haematoxylin solution for 15min
at room temperature, washed with water and stained with
eosin solution for 5min at room temperature. Samples were
dehydrated in ethanol solutions of growing order of grad-
ation (from 70 to 100). To assess calcium deposition, scaf-
folds were stained using 2% (w/v) alizarin red for 5min at
room temperature. Sections were dehydrated in ethanol
(from 70 to 100). All scaffold sections stained were eval-
uated under a Leica DMLB light microscope equipped with a
Leica DFC 320 high-resolution camera.
The scaffold sections were deposited on glass slides and
sputter-coated with graphite for 20 s to collect SEM images
and perform elemental mapping with energy dispersive X-ray
spectroscopy (EDS).
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Results
Scaffold preparation and characterization
Optimized PLGA MPs obtained with the solvent evaporation
technique had a particle size (dmv) in the range of
150–200 mm, suitable for preparing sintered scaffolds for tis-
sue regeneration (Figure 1(a,b)) [25]. The use of the double
emulsion preparation method made it possible to obtain MPs
with the high internal porosity required to assure fast degrad-
ation and increasing porosity over time (Figure 1(c)).
The scaffold preparation was performed using thermal sin-
tering. Incubation temperature and holding time were opti-
mized to guarantee the transition from the glassy to the
rubbery state of PLGA (PLGA Tg 38 C) and the fusion of
MPs in direct contact. Scaffolds that were easy to handle
without failure or loss of materials and that had a highly
interconnected pore structure were prepared by sintering
200mg of MPs at 60 C for 1 h.
Next, scaffolds were coated with CH and AL. Preliminarily,
CS and CH were used as model polymers to assess the suit-
ability of the experimental protocol to provide a uniform
coating layer on the scaffolds. Microanalysis spectra evi-
denced the presence of sulphur, attributed to the CS sulphate
groups only on the coating (Figure 1(d)), while the signal was
not measured in the scaffold cross section (Figure 1(e)). The
presence of the coating was also confirmed by ATR-FTIR ana-
lysis. Spectra of the PLGA, CH, CS alone and of the scaffold
coated with CH and CS were acquired. The spectrum of the
pure PLGA showed a sharp and high intensity peak at
1751 cm1, ascribed to the C¼O stretching of the ester
group [26]. CS spectrum showed a broad absorption in the
region of the –OH and –NH stretching modes
(3000–3650 cm1), ascribed to the hydroxyl and amino
groups present in the backbone, and two medium intensity
bands at 1608 and 1558 cm1, due to the C¼O stretching
and NH–CO bending vibration, respectively (Figure S1a). In
the CH spectrum, the same bands present in the CS spectrum
were observed, but at slightly different wavelengths: the
C¼O stretching and the NH–CO bending peaks were situ-
ated at 1647 and 1558 cm1. In the scaffold coated with CH
and CS, a broad band in the range of 3000–3600 cm1 and
two peaks at 1628 and 1539 cm1 were recorded. The inten-
sity of the last two peaks were equivalent to the sum of the
intensity of the corresponding peaks of the single biopoly-
mers, confirming the CH and CS contribution (Figure S1b). In
addition, a low intensity peak at 1743 cm1 was observed in
the coated scaffold spectrum, probably ascribable to the
C¼O stretching of PLGA under the coating layer
(Figure S1a). The shift to lower frequencies of the peaks of
the single polymers in comparison to those observed in the
scaffold spectrum suggests the formation of intermolecular
interactions between the polymers [27].
Scaffold degradation
In vitro mass loss studies showed a biphasic profile for both
the uncoated and coated scaffolds [28]. The first week was
characterized by low mass loss, while faster mass loss
occurred during the following weeks (Figure 2(a)). In the
second phase (from T7 to T28), the mass loss rate was com-
parable for both scaffolds (3.0184 day1 for the uncoated
Figure 1. SEM micrographs of PLGA microparticles, prepared using the solvent diffusion/evaporation method, at different magnification (a, b). Panel c of the cut
microparticle shows the inner particle porosity. Microanalysis spectra of the upper surface (d) and of the cross section (e) of the scaffold coated with chitosan/chon-
droitin-4-sulphate. The inserts show SEM micrographs of the scaffold upper surface (d) and cross section (e).
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scaffold and 3.4131 day1 for the coated one) and at
28 days, the residual mass was around 25% (Figure S2).
Scaffold degradation was also evaluated by GPC. First of
all, Mw of pure PLGA and MP were compared. The thermal
sintering technique did not significantly impact the polymer
Mw and polydispersity index (PDI). After the MP sintering pro-
cedure to obtain the scaffolds, a slight decrease in polymer
Mw (about 2%) was measured along with a variation in PDI
from 1.80 to 1.76 (data not shown).
The in vitro polymer hydrolysis of uncoated scaffolds was
studied at pH 7.4 in PBS for 21 days. Both Mn and Mw of scaf-
folds decreased exponentially with time throughout the deg-
radation period, according to the typically exponential decay
reported for this class of polymers (Figure 2(b)) [29]. Data
points were normalized considering polymer Mw and Mn of
the scaffolds incubated 1 h in PBS as 100%. The apparent
degradation rates based on Mw and Mn calculated using Eq.
(3), were estimated to be 0.0188 and 0.0133week1, respect-
ively. Degradation half times derived from Mw (Eq. (4)) were
about 2.3weeks. Polymer Mw distribution exhibited the
expected single peak. As the scaffolds degraded and low
molecular weight polymers were produced, the peak broad-
ened and shifted to the right, sometimes along with a small
shoulder. These features were in agreement with the changes
in PDI, which remained almost constant for about 10 days
until a significant decrease of Mw took place (Figure 2(c)).
Figure 2. Comparison of the residual mass between uncoated and coated scaffolds over the 28 days of the degradation period (a). Polymer Mw (b), Mn (b) and PDI
(c) profile of uncoated scaffolds during degradation. Photos of coated scaffolds at 1 h (T0), and 1 (T1), 7 (T7), 14 (T14) and 21 (T21) days of degradation in PBS
(0.1M, pH 7.4) at 37 C (d). SEM micrographs of the upper surface of the coated scaffold at different degradation times (e).
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In the case of coated scaffolds, the accuracy of GPC ana-
lysis was compromised, probably by the presence of residual
CH coating that could not be completely removed. Indeed,
ATR-FTIR data confirmed the presence of an interaction
between the PLGA scaffold and the coating. It can be
assumed that CH chains, which are positively charged, can
form electrostatic interactions with the PLGA negatively
charged surface. This feature is in agreement with the model
proposed by Guo and Gemeinhart. The adsorption of chito-
san follows a multilayer adsorption behaviour suggesting that
the adsorption of chitosan occurred on an energetically het-
erogeneous surface. Chemical heterogeneity (the distribution
of carboxylic end group and intermediate segments of PLGA
molecules) could also contribute to this interaction [30].
Scaffold morphology and structure were affected by the
biphasic degradation behaviour. Changes in size and surface
morphology of coated scaffolds are shown in Figure 2(d). In
the first stage of degradation (until T7), scaffold dimensions
basically remained unchanged, while in the late stage of deg-
radation, the scaffold surface gradually became irregular. As
reported in other works, the scaffold dimensions slightly
increased just before decreasing dramatically [31]. The same
behaviour was observed for uncoated scaffolds (data not
show). The SEM micrographs were in agreement with the
results of degradation studies. From hydration time T7, the
scaffold surface became irregular and rough, and MPs started
to lose their spherical shape. Interestingly, at T21, pores and
the interconnected structure were still visible (Figure 2(e)).
Mechanical test
PLGA is basically an elastic-plastic material, and in fact, the
pattern of slope did not show a precise yielding point.
Normally this event is more visible with low porosity [32], but
in our study the porosity, estimated from CT scans (Figure
3(a)), was higher than 85%, so the yielding peak vanished
from the curve. First, mechanical properties were evaluated
for dried scaffolds. In particular, average maximum compres-
sive stress was significantly higher (1.151 ± 0.058MPa) for
uncoated scaffolds when compared with the coated ones
(0.478 ± 0.005MPa). Young’s modulus for dry scaffolds was
also compared between uncoated and coated groups at 50%
and 75% of strain. Uncoated scaffolds showed a higher
Young’s Modulus at all strains (0.314 ± 0.095MPa vs
0.278 ± 0.076MPa at 50%; 0.949 ± 0.038MPa vs
0.526 ± 0.077MPa at 75% for uncoated vs coated scaffolds).
The difference was significant (p< .05) at 75% of strain.
Mechanical properties were then evaluated at five different
hydration times in PBS (0.1M, pH 7.4, 37 C): T0, T1, T7, T14,
Figure 3. Coated scaffold rendering of computed tomographic (CT) images (a). Compressive stress of uncoated (b) and coated (c) scaffolds and the Young’s modulus
at 50% (d) and 75% (e) of strain for the scaffolds after 1 h (T0) and 1 (T1), 7 (T7), 14 (T14) and 21 (T21) days of incubation in PBS (0.1M, pH 7.4) at 37 C. Data are
expressed as mean ± SD, p< .05 by student t-test.
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and T21 (1 h and 1, 7, 14, 21 days of hydration, respectively).
In Figure 3, results of uncoated (b) and coated (c) scaffolds
are shown as stress-strain curve slope, where stress was cal-
culated as the force per unit area and strain as the normal-
ized deformation induced in percentage. Significant
differences in compressive resistance were found at T0, T1
and T7 hydration time. Low compressive stress after 14 days
of hydration (T14) was not representative because the scaf-
folds were subjected to considerable degradation, which
drastically reduced their mechanical properties. Figure 3(d,e)
shows Young’s modulus at 50% and 75% of strain.
Differences between uncoated and coated scaffolds were all
statistically significant (p< .05) for T0, T1 and T7. Young’s
modulus tended to increase from T0 to T1, then it decreased
due to the scaffold degradation.
In vivo biocompatibility
Chorioallantoic membrane assay showed high biocompatibil-
ity of both uncoated and coated scaffolds. Digital images
captured five days after the deposition of coated scaffolds on
CAM surface showed a normal vascular growth without
adverse reactions or inflammation, generally recognized as
bleeding, ghost vessels and neoangiogenesis, around the
scaffold (Figure 4(a)). The absence of adverse reactions was
also confirmed by observing the CAM under the scaffolds
after sampling for histology (data not shown). Histological
examination confirmed the absence of toxicity and revealed
just a slight thinning of the CAM due to the scaffold weight
[33,34]. CAM had a normal histology without modification of
the ectoderm, mesoderm, or endoderm. Nucleated red blood
cells were normal as well. Of note, the coated scaffold
showed important and deep cell invasion, as evident in
Figure 4(b,c). Cells were found not only in the biopolymer in
direct contact with the biological substrate but also in the
scaffold porosity (Figure 4(c)). By a combination of capillarity
and biopolymer cell adhesion, cells penetrated the 3D struc-
ture of the scaffold deeper than 0.5mm. The scaffold acted
on CAM like a tissue graft [35]. The presence of the scaffold
on the CAM caused localized hypertrophy of the membrane
that reached more than 1mm thickness. In addition, the ecto-
derm in contact with the scaffold manifested the classical
reaction due to tissue fragment implantation. Ectoderm cells
started to proliferate very rapidly (presence of numerous
mitoses and multinuclear cells) and to invade the tridimen-
sional structure.
AD-MSCs immunophenotype
The surface marker expression of cultured AD-MSCs cells was
analysed using flow cytometry. The majority of the cells were
positive for CD73 (97.5 ± 2.12%), CD90 (89.5 ± 7.78%), CD105
(90 ± 9.89%) and negative for HLA-DR, CD271, CD14 and
CD16 (values <1%). These data indicated that the cells had
the mesenchymal-specific surface antigen pattern [36].
Osteogenic differentiation of AD-MSCs
AD-MSCs seeded onto coated scaffolds attached and adhered
to the surface first, but histological analysis (HE staining)
showed a gradual cell invasion and penetration into the poly-
mer matrix over time. At seven days from seeding, AD-MSCs
were mainly located on the scaffold surface, while, at 60 days,
cells proliferated and invaded the internal scaffold matrix
(Figure 5(a–d)). Over time, HE stained cells changed from
pink-red to blue, confirming a higher metabolic activity and
proliferation [37]. To evaluate calcium deposition and the
matrix mineralization, scaffold sections were also stained with
AR. Results showed no red staining in scaffolds harvested at
7 and 23 days (data not shown). Small calcium deposits were
present at day 35 while, at day 60, slices showed intense and
uniform red staining, which suggests that at 60 days of cul-
ture, the already degraded polymer matrix was mainly
replaced by mineralized bone matrix, composed essentially of
calcium phosphate salts (Figure 5(e–f0)). To confirm the pres-
ence of calcium phosphate, microanalysis was performed.
EDS data showed the presence of both Ca and P that co-
localize in the histological sections (Figure 5(g-g000)).
Discussion
PLGA is one of the most studied polymers in tissue engineer-
ing because of its high biocompatibility, tailored biodegrad-
ability and suitable mechanical properties [14,32]. In this
study, we used PLGA sintered MPs to build 3D scaffolds suit-
able for bone regeneration. Among the different methods
reported in literature, thermal sintering shows several advan-
tages. It allows the preparation of 3D scaffolds with high
inner interconnectivity and a tailored pore size, without the
Figure 4. CAM assay of the coated scaffold (a). Histology of the scaffold deposed on the CAM at 100 magnification (b) and 400 magnification (c). Scaffold
sections were stained with hematoxylin and eosin.
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use of porosigen agents, overcoming some drawbacks of
phase separation, gas foaming, and salt leaching techniques
[38]. In addition, particle sintering offers high surface area for
cell adhesion and expansion compared to that of other meth-
odologies. High porosity is an essential requirement for tissue
engineering applications, as it facilitates cell diffusion and
migration, ECM deposition and vessel penetration. A porous
surface also improves the integration between the implanted
scaffold and the surrounding tissue in vivo [39]. In the specific
case of bone regeneration, the scaffold porosity requirement
is even more important and it is essential to mimic, as much
as possible, the natural bone structure. Since human trabecu-
lar bone has a variable porosity that ranges between 50 and
90% of the bone volume [40], our scaffold is adequate to
reproduce the empty spaces of normal bone tissue.
However, PLGA and related polymers do not possess
adequate surface properties for cell adhesion and the use of
additional materials is needed. CH and AL are natural bio-
polymers that have been largely exploited in tissue engineer-
ing because of their osteoconductive properties [15,16,41].
Our data showed that a coating made of a combination of
these polymers creates a cell-friendly environment, and the
simple scaffold deposition on intact chicken CAM was suffi-
cient to allow cell invasion and penetration in the 3D struc-
ture (Figure 4).
A biodegradable scaffold must be able to maintain its
physical, chemical and mechanical properties until seeded
cells adapt to the environment and excrete sufficient
amounts of ECM. After the scaffold accomplishes its mission,
it has to be completely degraded and absorbed by the body
[14]. Polymer Mw was chosen to obtain a scaffold with fast
degradation, so that it can be replaced by ECM and mineral-
ized bone. It is important to point out that despite the fast
degradation rate, the scaffold residual mass was around 50%
after 21 days of incubation. Degradation studies data revealed
biphasic behaviour, which is to be expected for polyesters
that degrade via bulk degradation mechanism, and indicated
that there was low mass loss during the first week and faster
mass loss during the following weeks (Figure 2(a)).
Conspicuous mass loss does not start until the polymer
chains are reduced to a molecular weight that allows them to
solubilize and freely diffuse out of the matrix [14,42].
The degradation behaviour observed in our scaffolds fits
with the requirements for mesenchymal stem cell (MSC) dif-
ferentiation and osteogenesis. In fact, MSC osteogenesis and
osteoprogenitor differentiation can usually be divided into
different stages in vitro. Cell proliferation occurs during the
first four days, followed by an early differentiation from days
5 to 14. The final stage, from days 14 to 28, is characterized
by cell maturation and deposition of a mineralized matrix
[43,44]. In our study, at 21 days, the PLGA scaffold still pos-
sesses the adequate integrity and structure to provide 3D
support for cell maturation and matrix deposition.
In the current study, AD-MSCs were seeded on coated
scaffolds to verify their ability to support cell osteodifferentia-
tion and in vitro bone matrix deposition [45]. Histology con-
firmed that the scaffold supported cell adhesion, migration,
proliferation and differentiation. Our results showed the first
calcium deposits at 35 days, while intense and uniform red
staining was reached after 60 days (Figure 5(e0,f0)). Matrix
Figure 5. Cross section (16 mm) of the coated scaffolds at 7 (a), 23 (b), 35 (c) and 60 (d) days of culture in a commercial osteogenic differentiation medium
(LonzaTM). Sections were stained with HE staining methods. Comparison between scaffold sections stained with HE and AR at 35 (e, e0) and 60 (f, f0) days of culture
in the induction medium. Calcium deposits are stained in red (e0, f0). SEM micrograph (g) and microanalysis of a section of the scaffold at 60 days of culture in induc-
tion medium. Ca mapping (g0), P mapping (g00) and overlapping image (g000).
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mineralization is one of the most important indicators of in
vitro osteogenesis and of osteogenic differentiation of MSCs.
The temporal delay observed in matrix deposition, compared
to that reported in previous studies [43,44], can be ascribed
to the small number of cells seeded in relation to the high
void volume that characterized our scaffold. However, the
histology and microanalysis indicated that the biodegradable
scaffold was mainly replaced by mineralized bone matrix.
Conclusions
In this work, we prepared a composite PLGA scaffold suitable
for tissue engineering applications, in particular for bone tis-
sue regeneration. Scaffold characterization showed that the
sintering method seems to be a valid alternative to other
methods found in the literature to produce scaffolds. Our sin-
tered scaffolds possessed the porosity desired for bone tissue
regeneration. Scaffold coating with natural biopolymers (CH
and AL) improved scaffold mechanical properties as well as
cell adhesion and infiltration. The degradation rate, with a
residual mass of 50% at 21 days of degradation, demon-
strated the ability of the scaffold to support and sustain
seeded mesenchymal stem cells until their differentiation,
which occurred after approximately 21 days of culture.
Histological analysis confirmed that coated scaffolds were
osteoconductive and good candidates to sustain AD-MSC
adhesion, infiltration and osteogenic differentiation in pres-
ence of an induction medium. According to degradation time
and mechanical performance, this kind of scaffold could find
application in the healing of small defects in bones that may
not support high load or high mechanical stress.
Acknowledgements
The authors are indebted to Dr. Luca Poletti from Sereco Biotest www.
serecobiotest.it for the ATR-FTIR analyses. They would like to express
their gratitude to the LUNA (Laboratorio Universitario di Nanomateriali)
laboratory of the University of Perugia and in particular to Dr. Alessandro
Di Michele for SEM analysis and microanalysis. They would also like to
thank Sheila Beatty for editing the English usage in the manuscript.
Disclosure statement
No potential conflict of interest was reported by the authors.
References
[1] Tabata Y. Recent progress in tissue engineering. Drug Discov
Today. 2001;6:483–487.
[2] Langer R, Vacanti JP. Tissue engineering. Science. 1993;260:
920–926.
[3] Lanza R, Vacanti R, Vacanti JP. Principle of tissue engineering. 4th
ed. New York (NY): Elsevier Inc.; 2013.
[4] Shegarfi H, Reikeras O. Review article: bone transplantation and
immune response. J Orthop Surg (Hong Kong). 2009;17:206–211.
[5] The World Bank. Population projections; 2011. [Internet] Available
from: http://web.worldbank.org.
[6] Hoy D, Geere J-A, Davatchi F, et al. A time for action: opportuni-
ties for preventing the growing burden and disability from mus-
culoskeletal conditions in low- and middle income countries. Best
Pract Res Cl Rh. 2014;28:377–393.
[7] Oryan A, Alidadi S, Moshiri A, et al. Bone regenerative medicine:
classic options, novel strategies, and future directions. J Orthop
Surg Res. 2014;9:18–45.
[8] Henkel J, Woodruff MA, Epari DR, et al. Bone regeneration based
on tissue engineering conceptions - a 21st century perspective.
Bone Res. 2013;3:216–248.
[9] Giannoudis PV, Dinopoulos H, Tsiridis E. Bone substitutes: an
update. Injury 2005;36S:S20–S27.
[10] Albrektsson T, Johansson C. Osteoinduction, osteoconduction and
osseointegration. Eur Spine J. 2001;10:S96–S101.
[11] Vural AC, Odabas S, Korkusuz P, et al. Cranial bone regeneration
via BMP-2 encoding mesenchymal stem cells. Artif Cells Nanomed
Biotechnol. 2017;45:544–550.
[12] Chang H-I, Wong Y. Cell responses to surface and architecture of
tissue engineering. In: Eberli D, editor. Scaffolds regenerative
medicine and tissue engineering – cells and biomaterials. Croatia:
In Tech d.o.o.; 2011.
[13] Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaffolds
and osteogenesis. Biomaterials. 2005;26:5474–5491.
[14] Hutmacher DW. Scaffolds in tissue engineering bone and cartil-
age. Biomaterials. 2000;21:2529–2543.
[15] Di Martino A, Sittingerc M, Risbud MV. Chitosan: a versatile bio-
polymer for orthopaedic tissue-engineering. Biomaterials.
2005;26:5983–5990.
[16] Rowley JA, Madlambayan G, Mooney DJ. Alginate hydrogels as
synthetic extracellular matrix materials. Biomaterials. 1999;20:
45–53.
[17] Giovagnoli S, Blasi P, Schoubben A, et al. Preparation of large por-
ous biodegradable microspheres by using a simple double-emul-
sion method for capreomycin sulfate pulmonary delivery. Int J
Pharm. 2007;333:103–111.
[18] German RM. Sintering theory and practice. New York (NY): John
Wiley and Sons; 1996.
[19] Bertland P, Jonas A, Laschewsky A, et al. Ultrathin polymer coat-
ings by complexation of polyelectrolytes at interfaces: suitable
materials, structures and properties. Macromol Rapid Commun.
2000;21:319–348.
[20] Zhu H, Ji J, Shan J. Construction of multilayer coating onto poly-
(dl-lactide) to promote cytocompatibility. Biomaterials.
2004;25:109–117.
[21] Blasi P, Schoubben A, Traina G, et al. Lipid nanoparticles for brain
targeting III. Long-term stability and in vivo toxicity. Int J Pharm.
2013;454:316–323.
[22] Vargas A, Zeisser-Laboueb M, Lange N, et al. The chick embryo
and its chorioallantoic membrane (CAM) for the in vivo evalu-
ation of drug delivery systems. Adv Drug Deliv Rev. 2007;59:
1162–1176.
[23] Saw CLL, Heng PWS, Liew CV. Chick chorioallantoic membrane as
an in situ biological membrane for pharmaceutical formulation
development: a review. Drug Dev Ind Pharm. 2008;34:1168–1177.
[24] Altman R, Asch E, Bloch D, et al. Development of criteria for the
classification and reporting of osteoarthritis. Classification of
osteoarthritis of the knee. Diagnostic and Therapeutic Criteria
Committee of the American Rheumatism Association. Arthritis
Rheum. 1986;29:1039–1049.
[25] Oliveira MB, Mano JF. Polymer-based microparticles in tissue
engineering and regenerative medicine. Biotechnol Progress.
2011;27:897–912.
[26] Vey E, Rodger C, Booth J, et al. Degradation kinetics of poly(lactic-
co-glycolic) acid block copolymer cast films in phosphate buffer
solution as revealed by infrared and Raman spectroscopies. Polym
Degrad Stabil. 2011;96:1882–1889.
[27] Sun X, Wang J, Wang Y, et al. Collagen-based porous scaffolds
containing PLGA microspheres for controlled kartogenin release in
cartilage tissue engineering. Artif Cells Nanomed Biotechnol. 2017.
DOI:10.1080/21691401.2017.1397000
[28] Li S. Hydrolytic degradation characteristics of aliphatic polyesters
derived from lactic and glycolic acids. J Biomed Mater Res.
1999;48:342–353.
S228 S. CASAGRANDE ET AL.
[29] Selmin F, Blasi P, DeLuca PP. Accelerated polymer biodegradation
of risperidone poly(D, L-lactide-co-glycolide) microspheres. AAPS
PharmSciTech. 2012;13:1465–1472.
[30] Guo C, Gemeinhart RA. Understanding the adsorption mechanism
of chitosan onto poly(lactide-co-glycolide) particles. Eur J Pharm
Biopharm. 2008;70:597–604.
[31] Wu L, Ding J. In vitro degradation of three-dimensional porous
poly(d,l-lactide-coglycolide) scaffolds for tissue engineering.
Biomaterials 2004;25:5821–5830.
[32] Pan Z, Ding J. Poly(lactide-co-glycolide) porous scaffolds for tissue
engineering and regenerative medicine. Interface Focus. 2012;2:
366–377.
[33] Valdes TI, Kreutzer D, Moussy F. The chick chorioallantoic mem-
brane as a novel in vivo model for the testing of biomaterials. J
Biomed Mater Res. 2002;62:273–282.
[34] Schoubben A, Blasi P, Marenzoni ML, et al. Capreomycin supergene-
rics for pulmonary tuberculosis treatment: preparation, in vitro, and
in vivo characterization. Eur J Pharm Biopharm. 2013;83:388–395.
[35] Romanoff AL. The Avian Embryo. Structural and functional devel-
opment. New York (NY): The Macmillan Company; 1960.
[36] Kariminekoo S, Movassaghpour A, Rahimzadeh A, et al.
Implications of mesenchymal stem cells in regenerative medicine.
Artif Cells Nanomed Biotechnol. 2016;44:749–757.
[37] Fischer AH, Jacobson KA, Rose J, et al. Hematoxylin and eosin
staining of tissue and cell sections. Cold Spring Harb Protoc.
2008;3:1–2.
[38] Weigel T, Schinkel G, Lendlein A. Design and preparation of poly-
meric scaffolds for tissue engineering. Expert Rev Med Devices.
2006;3:835–851.
[39] Loh QL, Choong C. Three-dimensional scaffolds for tissue engin-
eering applications: role of porosity and pore size. Tissue Eng.
Part B Rev.2013;19:485–502.
[40] Kaplan FS, Hayes WC, Keaveny TM, et al. Form and function
of bone In: Simon SR editor. Orthopaedic basic science.
Rosemont (IL): American Academy of Orthopaedic Surgeons; 1994:
127–84.
[41] Asa’ad F, Pagni G, Pilipchuk SP, et al. 3D-printed scaffolds and bio-
materials: Review of alveolar bone augmentation and periodontal
regeneration applications. Int J Dent. 2016;2016:1239842.
[42] Agrawal CM, Huang D, Schmitz JP, et al. Elevated temperature
degradation of a 50:50 copolymer of PLA-PGA. Tissue Eng.
1997;3:345–352.
[43] Huang Z, Nelson ER, Smith RL, et al. The sequential expression
profiles of growth factors from osteoprogenitors to osteoblasts in
vitro. Tissue Eng. 2007;13:2311–2320.
[44] Birmingham E, Niebur GL, McHugh PE, et al. Osteogenic differenti-
ation of mesenchymal stem cells is regulated by osteocyte and
osteoblast cells in a simplified bone niche. Eur Cell
Mater.2012;23:13–27.
[45] Cai X, Su X, Li G, et al. Osteogenesis of adipose-derived stem cells.
In: Lin Y editor. Osteogenesis. Croatia: In Tech d.o.o.; 2012 pp
135–52.
ARTIFICIAL CELLS, NANOMEDICINE, AND BIOTECHNOLOGY S229
